Sio Gene Therapies Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2020 to Q4 2022

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Sio Gene Therapies Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2020 to Q4 2022.
  • Sio Gene Therapies Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending December 31, 2022 was 74M shares, a 0.87% increase year-over-year.
  • Sio Gene Therapies Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 73.2M shares, a 40.3% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 74M +640K +0.87% Oct 1, 2022 Dec 31, 2022 10-Q 2023-02-14
Q3 2022 74M +1.03M +1.42% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-10
Q2 2022 73.8M +903K +1.24% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-11
Q1 2022 73.2M +21M +40.3% Jan 1, 2022 Mar 31, 2022 10-K 2022-06-14
Q4 2021 73.3M +20.7M +39.2% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-14
Q3 2021 72.9M +26.2M +56.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 72.9M +29.6M +68.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 52.2M Jan 1, 2021 Mar 31, 2021 10-K 2022-06-14
Q4 2020 52.7M Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-11
Q3 2020 46.7M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 43.3M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.